Drug intelligence / Profile preview

parecoxib

Development stage
Phase 4
Lead developer
Pfizer
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Intravenous, Intramuscular
01

Overview

Parecoxib is a selective cyclooxygenase-2 (COX-2) inhibitor and nonsteroidal anti-inflammatory drug (NSAID) used for the short-term management of acute postoperative pain in adults. It is an injectable, water-soluble prodrug that is rapidly hydrolyzed in the body to its active form, valdecoxib. By selectively inhibiting COX-2, parecoxib reduces the synthesis of prostaglandins involved in inflammation, pain, and fever while sparing COX-1 activity associated with gastric protection and haemostasis. Parecoxib provides effective analgesia when oral administration is not feasible, such as during the perioperative period[1][2][4][5][7].

Brand names
Dynastat
Other names
parecoxib sodium
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PPARG (Peroxisome proliferator-activated receptor gamma)

Beyond the preview

Go deeper on parecoxib.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on parecoxib.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call